These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34146510)

  • 1. Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial.
    Wilbrink LA; de Coo IF; Doesborg PGG; Mulleners WM; Teernstra OPM; Bartels EC; Burger K; Wille F; van Dongen RTM; Kurt E; Spincemaille GH; Haan J; van Zwet EW; Huygen FJPM; Ferrari MD;
    Lancet Neurol; 2021 Jul; 20(7):515-525. PubMed ID: 34146510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective open label 2-8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headache.
    Brandt RB; Wilbrink LA; de Coo IF; Haan J; Mulleners WM; Huygen FJPM; van Zwet EW; Ferrari MD; Fronczek R;
    EBioMedicine; 2023 Dec; 98():104895. PubMed ID: 38007947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HortONS study. Treatment of chronic cluster headache with transcutaneous electrical nerve stimulation and occipital nerve stimulation: study protocol for a prospective, investigator-initiated, double-blinded, randomized, placebo-controlled trial.
    Fogh-Andersen IS; Sørensen JCH; Petersen AS; Jensen RH; Meier K
    BMC Neurol; 2023 Oct; 23(1):379. PubMed ID: 37865755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial.
    Goadsby PJ; Sahai-Srivastava S; Kezirian EJ; Calhoun AH; Matthews DC; McAllister PJ; Costantino PD; Friedman DI; Zuniga JR; Mechtler LL; Popat SR; Rezai AR; Dodick DW
    Lancet Neurol; 2019 Dec; 18(12):1081-1090. PubMed ID: 31701891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial.
    Wilbrink LA; Teernstra OP; Haan J; van Zwet EW; Evers SM; Spincemaille GH; Veltink PH; Mulleners W; Brand R; Huygen FJ; Jensen RH; Paemeleire K; Goadsby PJ; Visser-Vandewalle V; Ferrari MD
    Cephalalgia; 2013 Nov; 33(15):1238-47. PubMed ID: 23720502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Efficacy of Occipital Nerve Stimulation for Medically Intractable Cluster Headache.
    Leplus A; Fontaine D; Donnet A; Regis J; Lucas C; Buisset N; Blond S; Raoul S; Guegan-Massardier E; Derrey S; Jarraya B; Dang-Vu B; Bourdain F; Valade D; Roos C; Creach C; Chabardes S; Giraud P; Voirin J; Bloch J; Colnat-Coulbois S; Caire F; Rigoard P; Tran L; Cruzel C; Lantéri-Minet M;
    Neurosurgery; 2021 Jan; 88(2):375-383. PubMed ID: 32985662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study.
    Magis D; Allena M; Bolla M; De Pasqua V; Remacle JM; Schoenen J
    Lancet Neurol; 2007 Apr; 6(4):314-21. PubMed ID: 17362835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial.
    Obermann M; Nägel S; Ose C; Sonuc N; Scherag A; Storch P; Gaul C; Böger A; Kraya T; Jansen JP; Straube A; Freilinger T; Kaube H; Jürgens TP; Diener HC; Katsarava Z; Kleinschnitz C; Holle D
    Lancet Neurol; 2021 Jan; 20(1):29-37. PubMed ID: 33245858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occipital nerve stimulation improves the quality of life in medically-intractable chronic cluster headache: Results of an observational prospective study.
    Fontaine D; Blond S; Lucas C; Regis J; Donnet A; Derrey S; Guegan-Massardier E; Jarraya B; Dang-Vu B; Bourdain F; Valade D; Roos C; Creach C; Chabardes S; Giraud P; Voirin J; Bloch J; Rocca A; Colnat-Coulbois S; Caire F; Roger C; Romettino S; Lanteri-Minet M
    Cephalalgia; 2017 Oct; 37(12):1173-1179. PubMed ID: 27697849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial.
    Leroux E; Valade D; Taifas I; Vicaut E; Chagnon M; Roos C; Ducros A
    Lancet Neurol; 2011 Oct; 10(10):891-7. PubMed ID: 21903477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients.
    Burns B; Watkins L; Goadsby PJ
    Neurology; 2009 Jan; 72(4):341-5. PubMed ID: 19171831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic cluster headache with burst and tonic occipital nerve stimulation: A case series.
    Fogh-Andersen IS; Sørensen JCH; Jensen RH; Knudsen AL; Meier K
    Headache; 2023 Sep; 63(8):1145-1153. PubMed ID: 37602914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burst Occipital Nerve Stimulation for Chronic Migraine and Chronic Cluster Headache.
    Garcia-Ortega R; Edwards T; Moir L; Aziz TZ; Green AL; FitzGerald JJ
    Neuromodulation; 2019 Jul; 22(5):638-644. PubMed ID: 31199547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
    Riedl MA; Grivcheva-Panovska V; Moldovan D; Baker J; Yang WH; Giannetti BM; Reshef A; Andrejevic S; Lockey RF; Hakl R; Kivity S; Harper JR; Relan A; Cicardi M
    Lancet; 2017 Sep; 390(10102):1595-1602. PubMed ID: 28754491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated greater occipital nerve injections with corticosteroids in medically intractable chronic cluster headache: a retrospective study.
    Brandt RB; Doesborg PGG; Meilof R; de Coo IF; Bartels E; Ferrari MD; Fronczek R
    Neurol Sci; 2022 Feb; 43(2):1267-1272. PubMed ID: 34159486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
    Pivonello R; Fleseriu M; Newell-Price J; Bertagna X; Findling J; Shimatsu A; Gu F; Auchus R; Leelawattana R; Lee EJ; Kim JH; Lacroix A; Laplanche A; O'Connell P; Tauchmanova L; Pedroncelli AM; Biller BMK;
    Lancet Diabetes Endocrinol; 2020 Sep; 8(9):748-761. PubMed ID: 32730798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients.
    Miller S; Watkins L; Matharu M
    Eur J Neurol; 2017 Feb; 24(2):381-390. PubMed ID: 27995704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and interindividual attack frequency variability of chronic cluster headache.
    Brandt RB; Mulleners W; Wilbrink LA; Brandt P; van Zwet EW; Huygen FJ; Ferrari MD; Fronczek R;
    Cephalalgia; 2023 Feb; 43(2):3331024221139239. PubMed ID: 36739508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.